GLP-1 SM 15mg Peptides
Advance your research with a precise, consistent GLP-1 SM preparation built for disciplined laboratory work.
Well Elevation GLP-1 SM is supplied as a lyophilized peptide vial designed for controlled laboratory use, offering reliable handling and clear documentation. This single-vial format provides a total content of 15mg of GLP-1 SM peptide, presented as a stable powder to support methodical reconstitution and measured dosing in qualified research environments.
- Each vial contains 15mg of GLP-1 SM, suitable for investigations into receptor signaling, metabolic pathway modeling, and related assay development under established research protocols.
Engineered for workflow efficiency, the lyophilized format supports stability during storage and facilitates predictable reconstitution with appropriate laboratory-grade diluents. Researchers can expect a clean, professional presentation aimed at minimizing variables around handling, with clear labeling, lot tracking, and consistency that aids repeatability across studies.
Use cases include benchtop exploration, method optimization, and protocol validation where peptide quality and uniformity are essential inputs. The unbuffered, neutral presentation allows qualified teams to align solvent choice, concentration, and pH control with their validated procedures. This product is non-edible and intended strictly for laboratory environments—ideal for teams prioritizing accuracy, traceability, and dependable material integrity.
Every GLP-1 SM vial from Well Elevation reflects a rigorous approach to sourcing and quality control. Batches are produced under controlled conditions, with documented chain-of-custody and batch testing to verify identity and assess purity. As a USA-based research brand, Well Elevation emphasizes consistent specifications, transparent labeling, and clear compliance statements so research teams can work with confidence.
Trust & Safety
- USA-based supply with documented lot-level traceability
- Batch-tested for identity and purity
- Lyophilized format to support stability and consistent handling
- Clean labeling and clear storage/handling guidance
For laboratory research only. Not for human consumption or injection. Not a drug, medical product, or veterinary product. Use only by qualified professionals in appropriate research settings and follow all applicable guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Well Elevation are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
